Table 3.
Exhaustion/fatigue was at least briefly addressed by a: | ||||
---|---|---|---|---|
Treating physician | General practitioner | Nurse | ||
OR (95% CI) | OR (95% CI) | OR (95% CI) | ||
Sex | Female | 1.0 (Ref.) | 1.0 (Ref.) | 1.0 (Ref.) |
Male | 1.3 (1.0, 1.7) | 1.1 (0.8, 1.3) | 1.4 (1.0, 1.8) | |
Age | < 60 years | 1.0 (Ref.) | 1.0 (Ref.) | 1.0 (Ref.) |
60–70 years | 0.8 (0.6, 1.0) | 0.9 (0.7, 1.1) | 0.9 (0.7, 1.2) | |
≥ 70 years | 0.5 (0.4, 0.6) | 0.7 (0.6, 0.9) | 0.5 (0.4, 0.7) | |
BMI | Obese (≥ 30) | 1.0 (Ref.) | 1.0 (Ref.) | 1.0 (Ref.) |
Overweight (25–< 30) | 1.0 (0.8, 1.3) | 0.9 (0.7, 1.2) | 0.9 (0.7, 1.3) | |
Normal (18.5–< 25) | 1.1 (0.8, 1.4) | 0.8 (0.7, 1.1) | 1.0 (0.7, 1.3) | |
Underweight (< 18.5) | 1.7 (0.8, 3.7) | 0.9 (0.4, 1.9) | 2.0 (0.8, 5.0) | |
Chemotherapya | Never | 1.0 (Ref.) | 1.0 (Ref.) | 1.0 (Ref.) |
In the past | 1.8 (1.4, 2.2) | 1.1 (0.9, 1.5) | 2.8 (2.1, 3.8) | |
Recently/currently | 2.4 (1.5, 3.9) | 1.1 (0.7, 1.7) | 4.9 (2.9, 8.1) | |
Radiotherapya | Never | 1.0 (Ref.) | 1.0 (Ref.) | 1.0 (Ref.) |
In the past | 1.5 (1.1, 1.9) | 1.1 (0.8, 1.4) | 1.0 (0.7, 1.4) | |
Recently/currently | 1.1 (0.4, 2.9) | 2.0 (0.8, 5.1) | 1.7 (0.5, 5.3) | |
Targeted therapya | Never | 1.0 (Ref.) | 1.0 (Ref.) | 1.0 (Ref.) |
In the past | 1.5 (1.1, 2.0) | 1.0 (0.7, 1.4) | 1.1 (0.8, 1.6) | |
Recently/currently | 1.5 (0.9, 2.3) | 1.0 (0.6, 1.5) | 1.2 (0.7, 1.9) | |
Endocrine therapya | Never | 1.0 (Ref.) | 1.0 (Ref.) | 1.0 (Ref.) |
In the past | 1.0 (0.7, 1.5) | 1.2 (0.8, 1.7) | 0.9 (0.6, 1.5) | |
Recently/currently | 1.5 (0.9, 2.6) | 0.8 (0.5, 1.3) | 0.7 (0.4, 1.4) | |
Surgerya | Never | 1.0 (Ref.) | 1.0 (Ref.) | 1.0 (Ref.) |
In the past | 1.0 (0.7, 1.4) | 1.2 (0.9, 1.7) | 1.2 (0.8, 1.8) | |
Recently | 1.7 (0.7, 3.8) | 1.4 (0.7, 3.1) | 3.8 (1.6, 9.2) | |
Time since diagnosis | Per 1 year unit | 0.9 (0.8, 1.1) | 0.9 (0.8, 1.1) | 0.9 (0.7, 1.1) |
Entity | Breast | 1.0 (Ref.) | 1.0 (Ref.) | 1.0 (Ref.) |
Bladder | 0.7 (0.4, 1.2) | 0.7 (0.4, 1.3) | 0.4 (0.2, 0.9) | |
Cervix | 0.5 (0.2, 1.4) | 1.4 (0.5, 4.0) | 0.7 (0.2, 2.5) | |
Colon | 1.2 (0.7, 2.1) | 2.0 (1.1, 3.5) | 1.0 (0.5, 2.0) | |
Endometrium | 0.9 (0.5, 1.5) | 0.8 (0.5, 1.3) | 0.8 (0.4, 1.6) | |
Kidney | 0.7 (0.4, 1.2) | 0.9 (0.5, 1.5) | 0.4 (0.2, 0.9) | |
Leukemia | 2.7 (1.4, 5.2) | 1.4 (0.7, 2.7) | 1.1 (0.5, 2.4) | |
Liver | 6.4 (2.0, 21) | 3.2 (1.3, 8.2) | 2.0 (0.7, 5.9) | |
Lung | 1.2 (0.5, 2.8) | 1.8 (0.8, 4.1) | 0.9 (0.3, 2.4) | |
Malignant melanoma | 0.6 (0.3, 1.0) | 0.5 (0.3, 1.0) | 0.5 (0.2, 1.1) | |
Non-Hodgkin lymphoma | 1.7 (0.9, 3.0) | 1.4 (0.8, 2.4) | 1.1 (0.6, 2.2) | |
Other or multiple entities | 1.0 (0.3, 3.7) | 0.6 (0.2, 2.5) | 1.8 (0.4, 7.7) | |
Ovaries | 1.4 (0.8, 2.6) | 1.5 (0.8, 2.7) | 0.6 (0.3, 1.3) | |
Pancreas | 1.8 (0.7, 4.6) | 2.9 (1.2, 7.2) | 0.8 (0.3, 2.3) | |
Prostate | 1.1 (0.7, 1.9) | 0.9 (0.5, 1.5) | 0.5 (0.2, 1.0) | |
Rectum | 0.7 (0.4, 1.2) | 1.0 (0.6, 1.8) | 0.7 (0.3, 1.3) | |
Stomach | 1.1 (0.6, 2.1) | 1.6 (0.8, 2.9) | 0.5 (0.2, 1.1) |
The logistic models simultaneously include all listed factors
aRecently/currently, within the last 4 weeks; in the past, more than 4 weeks ago
Significant results (p < 0.05) are written in italics